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Abstract
Chloramphenicol has recently been criticised as antibacterial drug for cholera because
of probable inactivation in the body and appearance of resistant strains of Vibrio cholerae.
In the present study, chloramphenicol was compared with dihydroxymethyl furalazine in
regard to amount of diarrhea, reduction of vibrios in stool and the drug concentration in
stool and blood.
1. With oral administration of chloramphenicol, neither reduction of vibrios nor ele-
vation of drug level in stool were seen.
2. Two cases with intravenous administration of chloramphenicol revealed high concen-
tration of the drug and marked reduce of vibrios in stool.
3. In all cases with oral administration of furalazine, effective concentration of the
drug in stool was regularly found and at the same time, remarkable decrease of the
number of vibrios was recognized. Moreover, it was observed that vibrios disappeared in
stool in almost all cases, as the level of the drug showed further elevation.
4. An untoward reaction of furalazine, vomiting, was seen in one case.
Furalazine can be recommendedas a substitutional drug for treatment of cholera.
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Introduction
The choice of drugs for the treatment of a
infectious disease has been mainly based on
the sensitivity test of the etiologic organ-
ism. However, it should be noticed that the
effectiveness of chemotherapy is considera-
bly influenced by the pathophysiology of
the disease, and that it is closely related to
the distribution and the metabolism of the
drug in the body.
Cholera presents such an individual par-
ticular symptomatology 18X 23) among
bacterial infections that the distribution of
medicine given in the body is markedly
different from those of normal persons or
other diseases.13 >
The metabolism in vivo of the antibiotic,
such as chloramphenicol, depends greatly
upon the form of the drug and the route of
administration.
On the other hand, strains of El Tor vibrios
resistant to chloramphenicol and tetracycline
(which are most commonly used for the
treatment of chelera in the hospital) were
detected recently in the epidemic in the
Philippines. !6^ i?> It was proven that the
patients who excreted the resistant strains
failed to be treated clinically by these
drugs.
From these points of view, therefore, the
evaluation of the antibiotic treatment of
cholera should be re-investigated.
Chloramphenicol and tetracycline have
popularly i>s>4>5)8) i4> is>19)22) been
used for the treatment of cholera. From
the above mentioned point of view, however,
antibiotic treatment of cholera should be re-
investigated. At the same time, some drugs
which have a high and stable antibacterial
activity against V. cholerae should be search-
ed and a substitutional chemotherapy should
be established.
Dihydroxymethyl furalazine, one of the
derivatives of nitrofuran, has been examined
as one of the drugs which could answer the
purpose. !6> In the present study, a com-
parative investigation between furalazine
and chloramphenicol in regard to the mode
of action and effectivity was carried out in
order to clarify the mechanism of therapy
in cholera.
Materials and Methods
Since 1961, cholera El Tor has been
endemic in the Philippines, and an outbreak
has occurred every year in the rainy season
from June to October in the city and
suburbs of Manila.
The study has been carried out in Manila
as a part of the Joint Cholera Study between
the Pilippines-Japan and WHO.
Patients : Twenty-five adult patients with
typical cholera symptoms, admitted to San
Lazaro Hospital, Manila during September
through December in 1970 were investigated;
all patients were bacteriologically confirmed
and treated with lactated Ringer's solution
as long as diarrhea continued.
Collection of stool : The rectal rubber
tube, "The Health" No.16 Izumo Rubber
Manufacturing Co. Ltd., Tokyo, was in-
serted into the rectum continuously during
the examination of the patient, who was
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laid down on the cholera cot. The other
vend -of the catheter was connected to a
sterilized bottle which was calibrated. The
bottle was changed every 30 minutes and
the volume of the stool was measured and
recorded. The stool was continuously col-
lected for 6 to 14 hours depending on the
condition of the patient. A small portion
of collected stool was used for counting
vibrios and another portion was stocked in
a freezer for the determination of drug
concentration.
Collection of blood specimen : A few ml of
blood was taken from the patient on
admission and every 3 hours for the determi-
nation of drug concentration in serum.
And the plasma specific gravity was also
measured by copper sulfate method using
the same sample.
Quantitative examination of vibrios in stool :
TCBS agar was used for quantitation
of vibrios. Serial ten-fold dilution of stool
was made with normal saline solution. On
TCBS agar, O.lml of each diluent was streak-
ed by Conradi's glass stick. After overnight
culture, the numberof colonies was counted.
Drugs : Chloramphenicol powder in capsule
(250mg/cap.) was used for oral adminis-
tration, and chloramphenicol succinate for
intravenous injection. Both preparations
were provided by Parke Davis Co.
Dihydroxymethyl furalazine was used for
oral administration in form of granules. It
was provided by Toyama Chemical Co. in
Japan.
Dihydroxymethyl furalazine is a deriva-
tive of nitrofuran, and its chemical formula
is as follows.
This drug shows a wide spectrum of
antibacterial activity against various patho-
genic organisms, Gram-positive and -negative.
Particularly, Gram-negative rods as Shigella,










Administration of drugs : Drugs were admini-
stered as shown in Table 1. One dose
of each drug was given to the patient
before collecting of stool. No other medi-
cation was given except intravenous fluid
treatment during the period of examination.
Determination of the drugs in stool and serum : It
was carried out by the bioassay method.
a) Chloramphenicol
Composition qf medium used for the
bioassay was as follows.




23g of the mixture is diluted in
1000ml of distilled water and auto-
daved for 15 minutes at121°C
ii. 0.1^ methylene blue solution
iii. \% NaNO3 solution
iv. Indicator organism (Escherichia
coli, strain NIHJ)
E. coli, strain NIHJ, was cultured over-
night in the heart infusion broth. One or
two ml of the culture was added to 100ml
of Difco Nutrient Agar which was kept at
43-45°C in a water bath. Then, 3.8ml of
0.1^ methylene blue solution and 1 ml
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T able 1. Cases and Drugs.






































































CP : Chloramphenicol FL : Furalazine
of 1 % sodium nitrate solution were added.
After mixing them well, 1.5 or 2.0ml of the
melted agar which was prepared by the
above method was distributed in small test
tubes. The mixture in the test tubes was
kept at room temperature until the agar
became solid and successively stocked in
a refrigerator until used.
For the determination of chloramphenicol
level in stool and blood, the standard
curves were made by using the standard
chloramphenicol which was specially pre-
pared. As the solvents of the standard
drug, the plain rice watery stool was used
for the examination of stool and normal
human serum was prepared for the exami-
nation of blood.
The stool or serum specimens stocked in
the freezer were melted and homogenized
by shaking, and 0.3 or 0.4ml of each sample
was poured on the medium in the test tube.
After the test tubes were placed in a
refrigerator at 4°C for 3 to 4 hours, they
were incubated overnight at 37°C. The
length of the blue inhibitory zone appearing
in each tube was measured by using a slide
scale. The concentration of the active drug
in samples was determined by comparison
with the standard curve, which was made
simultaneously.
b) Dihydroxymethyl furalazine
i. Difco Nutrient Agar, sameas used
in determination of chloram-
phenicol
ii. \% methylene blue solution
iii. Bacterial suspension : Bacillus sut-
tilis PCI 219 was cultured on the
ordinary nutrient agar slant at 37°
C for 48 hours, and successively
placed in a refrigerator for 5 to 7
days to form the spores. The
organism was suspended in the
normal saline solution with a pro-
portion of one loopful organism
per one ml of saline solution.
Then, the bacterial suspension was
stocked in a refrigerator until
used.
In 100ml of Difco Nutrient Agar kept at
60°C, 0.15ml of \% methylene blue solution
and 0.3ml of bacterial suspension were
added. After mixing well by shaking, the
medium was distributed in test tubes with
the same method as for the chloramphenicol
bioassay.
The standard curve was drawn by the
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same procedure as was used for chloram-
phenicol determination.
The stool or serum for examination was
melted and homogenized by shaking. 0.3
or 0.4ml of each sample was placed on
the medium in the test tubes. Then, they
were placed in a refrigerator for two
hours and successively incubated overnight
at 37°C. Reading of the result was taken
after incubation.
Results
1) Volume of stool
During the period of the study, the volume
of stool excreted during each 30 minute peri-
od is shown in Table 2. The samples were
Table 2- The volume of stool collected in
every 30 minute period and its frequency
Volume Frequency %
0 - 50 ml 48 9.7
50 - 100 69 14.0 ^
100 - 200 99 20.1
91.2
200 - 300 104 21.1
300 - 400 71 14.5
400 - 500 58 ll.8
500 - 600 16 3.2 ^
600 - 700 16 3.2
700 - 800 5 1.0
1 8.8
800 -900 2 0.4 /
900 - 1000 3 0.6
1000- 2 0.4 I
Total 493 100 %
taken 493 times altogether. The volume
between 0 and 500ml was seen is 449 samp-
lings out of 493 (91.2^). In 42 samplings the
volume showed morethan 500 ml. The largest
amount, morethan 1000ml, was found twice.
Generally the volume of stool excreted in
30 minutes was almost constant in each
case,except one or two hours after the be-
ginning of rehydration. In 9 cases which
showed high plasma specific gravity, the
amount of stool for first 1 or 2 hours was
especially small.
2) Relation between volume of stool and
number of vibrios
On admission the number of vibrios in
stool was the same (107-109/ml) in every
patient who had not been given antibacterial
drugs. The fact was not related to the
amount of stool on admission.
In 5 cases (1,5, 7,9, 16), the number of
viable vibrics in stool started to decrease in
2 to 3 hours after administration of the drug,
especially furalazine, although diarrhea still
continued in the same amount as before.
Even in 3 cases (7, 9, 16) whose stool con-
tained no vibrios for several hours, it was
observed that the volume of stool every 30
minutes showed no considerable change.
It was noticed that there was no relation
between the volume of stool and the number
of vibrios in stool during the early stage of
chol era.
3) Influence of drugs on volume of stool
a) Furalazine
In twelve cases given furalazine orally, no
marked change in the stool volume wasfound
during the period of collection. As shown
in fig. 1 (case No. 7), the stool volume during
each 30 minutes amounted to 200 to 400ml,
mostly approximately 400ml, for 9 hours after
the oral administration of 250mg furalazine.
However,no tendency to reduce in stool a-
mount was noted during the period of
observation.
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tO Chloramphenicol
Chloramphenicol was given orally 250mg
in 6 cases and SOOmgin 4 cases. Three cases
with intravenous administration of lOOOmg

















cases having oral treatment.
No case showed remarkable difference in
the volume of stool during every 30-minute
period for 9 hours more or less after the
medicat ion.





« =.10 ll 12 13hrs.
Fig. 2
As indicated in fig. 3 (case No. 17),the
volume of stool during every 30-minute peri-
od ranged from 100 to 700ml. Difference of
amount seemed not to be related to the time
after the medication.


















It was observed in all cases that the
number of vibrios in stool began to decrease
mainly after 3 to 4 hours after the oral ad-
ministration of 250mg of furalazine. How-
CASE NO. 17 CHLORAMPHENICOL 250mg oral
f \. / *
~*o
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Hours after Medication
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ever, in case No. 6 (fig. 4) whose stool was not copious, the number of vibrios was not






















V olume of Stool
reduced until 7 hours after the start of (fig. 5) which showed vomiting soon after
treatment. The reduce in the number of the medication,






















CASE NO.8 FURALAZINE 250mgor^l
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V olume of Stool
The time from the beginning of decrease of vibrios until the elimination of vibrios in
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stool was 2 to 8 hours. For instance, in
cases No. 1 (fig. 6) and 5 (fig. 7), thereduce





















medication in both eases, and vibrios dis-
appeared from the stool in the fifth hour in
case No. 5 and the tenth hour in case No. 1.













It was noticed in cases treated with
chloramphenicol that the decrease of vibrios












V olume of Stool
number of organisms decreased gradually in
some cases. The results were not widely
different between the groups receiving 250mg
and SOOmg of oral administration (fig. 9, 10).
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Fig.9
H ours after Medication
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yc Number of Vibrios in Stool after Medication
9 . CP 250mfi oral
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However, in the control cases with intra- decreasedmarkedly after the injection ofchlo-
venous treatment, the number of vibrios ramphenicol as shown in fig.12 (case No.4).
CASE NO.23 CHLORAMPHENICOL SOOmgoral
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5) Concentration of drugs in stool and serum
a) Furalazine
The effective concentration of furalazine
was considered to be approximately
O.lmcg/ml of the stool, considering the
sensitivity of isolated vibrios to furalazine
and the reduce of vibrios in stool. The
stool with effetive concentrationof drug
began to be evacuated 3 to 5 hours after
medication, mostI}7 in 4 hours.
The maximumconcentration in the stool
ranged from 4.0 to 50mcg/ml of stool, and it
was reached within 5 to 9 hours, except for
one case, which took 14 hours as seen in
Table 3.
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T able 3. Concentration of Drugs and Number of Vibrios in Stool
When the reduce of vibrios was
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* medication was given before admission






























There was no relation between the concen-
tration of drug and volume of stool in each
30 minutes. On the contrary, the number of
vibrios was closely correlated to the concen-
tration of the drug in the stool. The reduce
of vibrios was usually recognized when the
concentration of the drug reached an ef-
fective level.
It was seen, in other words that the sooner
the drug concentration became effective, the
morerapidly the number of vibrios decreased.
The elimination of vibrios in the stool
was not achieved in case No. 8 (fig. 5)
which failed to receive a sufficient dose
of the drug because of vomiting and of
which the concentration was not high
enough.
In the majority of cases, a high concen-
tration continued for about 4 hours. In three
cases, the number of vibrios increased again
as the drug level came down.
Yellowish-colored watery stool was ob-
served within 4 to 5 hours after the adminis-
tration of furalazine, which indicated a
higher concentration of the drug, higher than
3mcg/ml of stool.
According to the bioassay determination,
the drug was not detected in the blood of
any patient except one, in whom the drug
was slightly proven, as shown in Table 4.
Evaluation of Effectiveness of Chemotherapy in Cholera 37
T able 4. Concentration of Drugs in Blood. (Bioassay)
C ase No






















































































































The concentration of Chloramphenicol in
stool was extremely low in the majority
of cases given 250mg or BOOmg of Chloram-
phenicol orally. Only 2 cases indicated
30mcg/ml in the eighth hour (case No. 10)
and 17.5mcg/ml (case No. 17) after the
seventh hour as indicated in Table 3.
It was, however, noticed that the number
of vibrios in stool did not decrease even in
cases which revealed a higher concentration
of chloramphenicol.
In two cases out of three receiving intra-
venous administration of 1000mg chloram-
phenicol, rapid and marked decrease of
vibrios in stool was seen, as well as
higher concentration of the drug in stool.
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of the drug in stool was low within 6 hours


























viable count showed no remarkable reduce
until eighth hour.
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D rug concentrationin Stool
Volume of Stool
The blood concentration of the drug is
shown in Table 4. A difference between
the oral group of 250mg chloramphenicol and
that of 500mg was seen ; three cases in the
latter group indicated high concentration
within 3 hours, although little or nothing
of the drug was found in the former.
T able g. Drug Sensitivity Test of El Tor Vibrios isolated














CP : Chloramphenicol TC : Tetracycline
SM : Streptomycin FL : Furalazine
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Discussion
It has been well known in the recent past
that antibiotics are effective for reducing
the duration of diarrhea and excretion of
vibrios in stool, and chloramphenicol and
tetracycline are popularly used for the treat-
ment of cholera cases. i> s> 4> s> 8>i4> 151
However, some undesirable results of
chloramphenicol treatment for cholera have
been noted by Iwanaga et al. *3) And also
it has been reported that several cases
failed to be responded to chloramphenicol
because of resistant strains to the drug. 16;>
At the same time, the mechanism of the
effects of antibacterial treatment of cholera
has not been fully clarified.
In-_this situation, it was considered that
the'; antibacterial therapy of cholera should
be re-investigated precisely.
For the purpose of the study, the volume
of stool which was collected in each 30-
minute period, the number of vibrios in
these samples and the concentration of the
drug in stool and blood were investigated
during the first few hours after admission.
The volume of stool collected within one
or two hours after admission was different
individually; in some cases with severe dehy-
dration only a small amount of stool was
excreted and in other cases, the volume of
the first collected sample was extraordinari-
ly large, probably because of retention of
fluid in the rectal ampulla.
The volume of stool collected in each 30-
minute period became almost constant from
about 2 hours.after the treatment, although
a slight fluctuation of the volume was seen
in some cases.
It was noteworthy that the volume of
stool was not influenced by any antibacterial
treatment.
It was confirmed that there was no re-
lation of the amount of stool with the type,
dosage and route of administration of the
drug. In addition, the concentration of the
drug was not correlated to the volume of
stool.
On the other hand, the number of vibrios
wasusually 107-109/ml of stool on admission.
It was supposed that the multiplication of
vibrios in the intestine was inhibited at the
threshold of 109/ml. 8) 10 24)
It was noted that there was no pro-
portion between the stool amount and the
number of vibrios. 245
Diarrhea continued for a few hours even
when vibrios disappeared from the stool.
This fact should be important in view of
the pathogenesis of diarrhea. 2 >
It implies that no growth or presence of
vibrios in the intestine is needed for con-
tinuation of diarrhea. It is presumed that
diarrhea may continue for at least 10 hours
by means of a single stimulation of the in-
testinal mucosa as the trigger theory. 2)
It has been shown that the amount of
stool can. not be a criterion for the compari-
son of effectiveness between chloramphenicol
and furalazine. Thus, a change of the
number of vibrios can be only one indicator
to decide the effect of the drug.
Changes of number of vibrios in caass
with oral administration of 250mg and SOOmg
chloramphenicol are summarized in fig. 9
and 10. No marked reduce of vibrios was
found in any case; particularly in group re-
ceiving 250mg chloramphenicol, some cases
showed almost no change of the number of
vibrios for about 10 hours after the medica-
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tion. Even in cases of 500mg chloram-
phenicol, the decrease of vibrios was gradual
and not satisfactory. There were no cases
in which vibrios disappeared from the
stool. The fact should be due to the low
concentration of drug in the stool, except
in two cases.
On the other hand, concentration of chlor-
amphenicol in the blood was rather high in
cases of oral 500mg administration, although
the drug appeared in little concentration in
the blood of cases receiving 250mg chloram-
phenicol.
Anyway,a paradoxical finding of the drug
concentration of stool can not be compre-
hended by the blood concentration in both
groups.
It is presumed that a large part of the
drug may be inactivated in the intestine.
Twocases with intravenous administration
of lOOOmg of chloramphenicol out of 3 cases
showed a striking difference from those
with oral administration in regard to the
reduce of vibrios and the drug concentration
in the stool.
The same finding was mentioned by
Iwanaga et al, is> and was confirmed by the
previous experience of the author in 1969.
It is not clear whether the difference
between the oral and intravenous admini-
stration should be due to preparation of
chloramphenicol, succinate and ordinary
powder, or the route of administration.
From the public health point of view, it
should be a priority to eliminate vibrios
from the stool of the patient as soon as
possible. For this purpose, intravenous
administration is more satisfactory than
oral within the first few hours after admis-
sion. 24)
It has been observed at San Lazaro Hospital
that chloramphenicol wasless effective than
before for treatment of cholera patients ;
particulary the duration of positive culture
for Vibrio cholerae has been prolonged in
some cases in spite of strains sensitive to
chloramphenicol.
Moreover, several resistant strains to chlo-
ramphenicol have been found since 1969. 16)
Such a situation in treatment of cholera
has demanded some substitutional drugs for
the antibacterial treatment of cholera.
L^ According to the sensitivity test shown
in-iTable 5, dihydroxymethyl furalazine was
selected because of its highest sensitivity.
As far as the concentration of furalazine
is concerned, the drug reached an effective
concentration in stool within 2 to 4 hours,
while it was not proven in blood in almost
all cases; it was presumed that the major
part of the drug can be excreted in stool
without absorption. 12) 25)
It is worth noticing that the number of
vibrio indicated the tendency of rapid
decrease in the majority of cases taking
furalazine orally. Furthermore, it should
be emphasized that vibrios disappeared
completely in stool in almost all cases.
The reduce and elimination of vibrios in
the stool was comprehensible by means of
drug concentration in stool. In other words,
the drug was excreted in satisfactory con-
centration to kill the vibrios.
Furalazine was used in form of yellowish
granules. It was noticed that yellowish
watery stool was found within about five
hours after administration in some cases.
This phenomenon can be helpful to
estimate the time that the drug takes to
pass through the intestine. It can give an
useful guide in deciding the intervals of
drug administration.
In conclusion, furalazine was much more
effective than chloramphenicol concerning
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the reduce or elimination of vibrios in stool.
Besides, since the effect of 250mg fur-
alazine was superior to SOOmg chloram-
phenicol, it is more than twice as effective
as chloramphenicol for treatment of cholera.
One other kind of the nitrofuran deriva-
tives was reported as chemotherapeutica by
Chaudhuri et al6)7) and Pierce et al. 2o>
However, the sensitivity of this drug is
inferior to that of furalazine.
This drug was compared preliminarily
with other antimicrobial agents for its effect
in reducing the duration of diarrhea and
excretion of vibrio in stool. 15;>
Only one disadvantage of the drug (fur-
alazine) is nausea and vomiting caused by
stimulation of stomach. However, the
vomiting was not frequently seen.
S ummary
Twenty five adult patients with typical
cholera symptoms, admitted to San Lazaro
Hospital, Manila, were investigated. Chloram-
phenicol was compared with dihydroxy-
methyl furalazine in regard to amount of
diarrhea, reducing the vibrios in stool and
concentration in stool and blood after taking
it.
1. With oral administration of chloram-
phenicol, neither reduction of vibrios nor
elevation of drug level in stool were seen.
2. Two cases with intravenous administ-
ration of chloramphenicol revealed high
concentration of the drug and marked
reduction of vibrios in stool.
3. In all cases with oral administration
of furalazine, effective concentration of
the drug in stool was regularly found and
at the same time, a remarkable decrease
of the number of vibrios was recognized.
Moreover, it was observed that the vibrios
disappeared from the stool in almost all
cases, as the level of the drug showed
further elevation.
4. An untoward reaction of furalazine,
vomiting, was seen in one case.
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